| Contact Information |
University of Illinois at Chicago
Section of Digestive Diseases and Nutrition
840 South Wood Street (M/C 716)
Chicago, Illinois 60612
(T) 312-569-7997
(F) 312-996-5103 |
| Education & Training |
College: Duke University, Durham, NC (1978-1982; history major)
Medical School: Wake Forest University, Winston-Salem, NC (1982-1986)
Residency: University of Illinois Hospital, Chicago, IL (Internal Medicine, 1986-1989)
Fellowship: Georgetown University Medical Center, Washington, DC (Gastroenterology, 1990-1991)
Postdoc: Digestive Diseases Branch, National Institutes of Health, Bethesda, MD (1991-1995)
|
| Basic Research Interests |
More information regarding my laboratory can be found by turning to the Benya Lab Home Page
My major research focus concerns the processing and regulation of 7-transmembrane spanning, G protein-coupled (heptaspanning) receptors. Specifically, I am studying the receptors for gastrin-releasing peptide and for galanin.
My ongoing studies for the Gastrin-releasing peptide (GRP) receptor include determining the mechanisms that regulate its desensitization, or turn it off after being activated. This is of particular importance since the GRP receptor has been shown to be present on cancers arising from the GI tract, and when activated cause these cancers to grow.
The galanin receptor has been shown to be centrally involved in regulating weight gain. Therefore my laboratory is in the process of determining this receptor's chromosomal location, genomic structure, and factors involved in regulating its expression. These studies should result in future pharmacological agents that modulate this receptor, and thus may help to regulate weight gain.
|
| Clinical Interests |
My major clincial interest concerns the evaluation, diagnosis and treatment of individuals with GI endocrine tumors. Such tumors include gastrinomas causing the Zollinger-Ellison syndrome, insulinomas, and carcinoid tumors, among others. I also have a longstanding interest in nutrition and the nutritional support of the severely ill patient. This interest is backed by a reseach focus into the mechanism whereby key peptide hormones modulate or otherwise effect the GI tract. |
|
BACK TO DDN HOME
|
|